Live Breaking News & Updates on Fellowship Fund In Psychedelic Neuroscience At Massachusetts

Stay updated with breaking news from Fellowship fund in psychedelic neuroscience at massachusetts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform

- Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase 2a proof-of-mechanism data with RL-007 in cognitive ....

New York , United States , San Diego , City Of , United Kingdom , Camilla Dormer , Srinivas Rao , Otsuka Pharmaceuticals , Fellowship Fund In Psychedelic Neuroscience At Massachusetts , Recognify Life Sciences , Hospital Center , Revixia Life Sciences , Exchange Commission , Multidisciplinary Association For Psychedelics Studies , Viridia Life Sciences , Life Sciences , Securities Exchange , Introspect Digital Therapeutics , Greg Weaver , Chief Financial Officer , Chief Scientific Officer , Florian Brand , Chief Executive Officer , Fellowship Fund , Psychedelic Neuroscience , Massachusetts General Hospital ,